Hu Luo Selected Research

Hu Luo Research Topics

Disease

7	Lung Neoplasms (Lung Cancer) 03/2024 - 12/2011
6	Neoplasms (Cancer) 03/2024 - 12/2013
3	Cognitive Dysfunction 01/2024 - 01/2022
2	Thalassemia 11/2023 - 10/2023
2	Adenocarcinoma of Lung 09/2023 - 03/2023
2	Liver Neoplasms (Liver Cancer) 08/2023 - 01/2023
2	Alzheimer Disease (Alzheimer's Disease) 04/2023 - 08/2022
2	Neuroinflammatory Diseases 04/2023 - 08/2022
2	Carcinogenesis 01/2023 - 04/2017
1	Inflammation (Inflammations) 01/2024
1	Asthma (Bronchial Asthma) 01/2024
1	Sickle Cell Anemia (Hemoglobin S Disease) 12/2023
1	Pneumonia (Pneumonitis) 12/2023
1	Breast Neoplasms (Breast Cancer) 11/2023
1	Malignant Pleural Effusion 09/2023
1	Lung Diseases (Lung Disease) 01/2023
1	Sepsis (Septicemia) 01/2023
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2023
1	Silicosis 01/2023
1	Prostatic Neoplasms (Prostate Cancer) 12/2022
1	Huntington Disease (Huntington's Disease) 08/2022
1	Parkinson Disease (Parkinson's Disease) 08/2022
1	Substance-Related Disorders (Drug Abuse) 08/2022
1	Acute Lung Injury 03/2022
1	Lung Injury 03/2022
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 12/2021
1	COVID-19 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 01/2021
1	Fibrosis (Cirrhosis) 04/2019
1	Chronic Hepatitis B 04/2019
1	Liver Cirrhosis (Hepatic Cirrhosis) 04/2019
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 04/2017
1	Tuberculosis (Tuberculoses) 01/2013

Drug/Important Bio-Agent (IBA)

6	DNA (Deoxyribonucleic Acid)IBA 12/2023 - 04/2019
4	Biomarkers (Surrogate Marker)IBA 03/2024 - 12/2022
3	MicroRNAs (MicroRNA)IBA 03/2024 - 10/2023
3	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2024 - 01/2022
3	graphdiyneIBA 12/2023 - 11/2023
3	InflammasomesIBA 04/2023 - 01/2022
3	Proteins (Proteins, Gene)FDA Link 04/2023 - 01/2021
2	Neuroprotective AgentsIBA 01/2024 - 01/2023
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2023 - 01/2021
2	Nucleic AcidsIBA 10/2023 - 08/2023
2	Cisplatin (Platino)FDA LinkGeneric 02/2018 - 04/2017
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2024
1	Neprilysin (Neutral Endopeptidase)IBA 01/2024
1	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2024
1	AntioxidantsIBA 01/2024
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2024
1	GoldIBA 12/2023
1	EnzymesIBA 11/2023
1	ErbB Receptors (EGF Receptor)IBA 09/2023
1	Carcinoembryonic AntigenIBA 09/2023
1	molybdenum disulfideIBA 08/2023
1	CarbonIBA 08/2023
1	Tumor Biomarkers (Tumor Markers)IBA 08/2023
1	CytokinesIBA 04/2023
1	Amyloid beta-PeptidesIBA 04/2023
1	Gefitinib (Iressa)FDA Link 03/2023
1	Histamine H3 Receptors (Histamine H3 Receptor)IBA 01/2023
1	Aurora Kinase AIBA 01/2023
1	Pregnane X ReceptorIBA 01/2023
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2023
1	thioperamideIBA 01/2023
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2023
1	huachansuIBA 01/2023
1	2-chloro-5-nitrobenzanilideIBA 03/2022
1	Pioglitazone (Actos)FDA Link 03/2022
1	LipopolysaccharidesIBA 03/2022
1	Organophosphorus CompoundsIBA 12/2021
1	isocarbophosIBA 12/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	GlucocorticoidsIBA 01/2021
1	nasIBA 04/2019
1	TabletsIBA 04/2019
1	biejia ruanganIBA 04/2019
1	Hepatitis B e AntigensIBA 04/2019
1	Small Interfering RNA (siRNA)IBA 02/2018
1	SurvivinIBA 02/2018
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 02/2018
1	Tyrosine (L-Tyrosine)FDA Link 04/2017
1	Non-Receptor Type 11 Protein Tyrosine PhosphataseIBA 04/2017
1	Conditioned Culture MediaIBA 12/2013
1	Prealbumin (Transthyretin)IBA 01/2013
1	Therapeutic UsesIBA 01/2013
1	Indicators and Reagents (Reagents)IBA 01/2013

Therapy/Procedure

3	Therapeutics 02/2018 - 12/2011
1	Drug Therapy (Chemotherapy) 03/2023
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 04/2019